"Phobie à deux" and other reasons why clinicians do not apply exposure with response prevention in patients with obsessive-compulsive disorder.


Journal

Cognitive behaviour therapy
ISSN: 1651-2316
Titre abrégé: Cogn Behav Ther
Pays: England
ID NLM: 101143317

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 2 8 2018
medline: 17 3 2020
entrez: 2 8 2018
Statut: ppublish

Résumé

Meta-analyses suggest that exposure with response prevention (ERP) is the most efficacious treatment for obsessive-compulsive disorder (OCD) and treatment guidelines for the disorder accordingly recommend ERP. Despite this, many therapists, including those with a cognitive-behavioral therapeutic background, do not perform ERP in patients with OCD. The present study aimed to elucidate the reasons why. German therapists (N = 216) completed an anonymous online survey, the newly developed Reasons for Not Performing Exposure in OCD Scale (REPEX), that inquired whether, to what extent, and how they perform ERP in the treatment of OCD. We also asked their reasons for not applying ERP in the past. Most therapists considered ERP an efficient treatment for OCD. Marked differences emerged between physicians and psychologists, however. The former used exposure less often and for a shorter period, preferred in sensu to in vivo exposure, and conducted exposure less often in the personal environment of the patient than did psychologists. Both groups were familiar with clinical guidelines to a similar extent. A factor analysis of the REPEX scale revealed five factors. Patient lack of motivation, preference for exposure to be self-help as well as alleged organizational difficulties were endorsed most often. The latter was correlated with the age of the therapist and was far more often affirmed by physicians. Fear of side effects was named by a subgroup of clinicians; in the context of patient ambivalence, this may foster "phobie à deux". Unlike prior research, lack of expertise was rarely identified as a reason not to use ERP. Recommendations for improving adherence to guidelines are discussed.

Identifiants

pubmed: 30064295
doi: 10.1080/16506073.2018.1494750
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

162-176

Auteurs

Steffen Moritz (S)

a Department of Psychiatry and Psychotherapy , University Medical Center Hamburg-Eppendorf , Hamburg , Germany.

Anne Külz (A)

b Clinic of Psychiatry and Psychotherapy , University Medical Center Freiburg , Freiburg , Germany.

Ulrich Voderholzer (U)

c Schoen Clinic Roseneck , Prien , Germany.
d Department of Psychiatry and Psychotherapy , University of Munich , Munich , Germany.

Thomas Hillebrand (T)

e Psychotherapeutic Practice , Münster , Germany.

Dean McKay (D)

f Department of Psychology , Fordham University , Bronx , NY , USA.

Lena Jelinek (L)

a Department of Psychiatry and Psychotherapy , University Medical Center Hamburg-Eppendorf , Hamburg , Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH